title: Ubretid (distigmine bromide) taken to treat urinary retention prolongs the effect of suxamethonium.
authors.forename: Shiroh
authors.initials: S
authors.lastname: Isono
authors.forename: Kei
authors.initials: K
authors.lastname: Iizuka
authors.forename: Goro
authors.initials: G
authors.lastname: Fukami
authors.forename: Norihiro
authors.initials: N
authors.lastname: Shinozuka
authors.forename: Masaomi
authors.initials: M
authors.lastname: Iyo
authors.forename: Takashi
authors.initials: T
authors.lastname: Nishino
mesh_terms: D000328:Adult; D004347:Drug Interactions; D006801:Humans; D008297:Male; D009467:Neuromuscular Depolarizing Agents / Q000494:pharmacology*; D011726:Pyridinium Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D013390:Succinylcholine / Q000494:pharmacology*; D016055:Urinary Retention / Q000188:drug therapy*
chemical_list: D009467:Neuromuscular Depolarizing Agents; D011726:Pyridinium Compounds; D013390:Succinylcholine; C084645:distigmine